Uma Chaudhry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Uma Chaudhry has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Abdelrahman H. Abdelmoneim
Sudan Medical Specialization Board, Sudan
1 shared publication- Abhishek Sharma
Centre for Systems Biology and Bioinformatics, Panjab University Chandigarh, India
1 shared publication - Ali Gharip
Bioinformatics Review- nCoV-2019 Drug Development Team
1 shared publication - Alka Pawar
Dr. B. R. Ambedkar Center for Biomedical Research, Delhi School of Public Health, IoE, University of Delhi, Delhi, India
1 shared publication Ankit Gupta
Bioinformatics Review- nCoV-2019 Drug Development Team
1 shared publication- Anoushka Khanna
Department of Biomedical Sciences Bhaskaracharya College of Applied Sciences University of Delhi 110075 New Delhi
1 shared publication
Latest Publications
- Open Access
- 29 November 2023
- Published by Green Publication
- Vol. 44 (5) , 1351-1361
Bacterial contamination and associated antibiotic resistance in Fresh Produce : A comparative study between retail outlets and local markets
The consumption of food is essential for human survival, but the presence of bacterial pathogens in fresh produce can pose significant risks to public health by causing severe foodborne and enteric diseases. With this concern in mind, our study aimed to assess the contamination levels of specific bacterial species, E. coli, Salmonella spp., and Staphylococcus aureus, in various fresh produce items (pear, guava, apple, carrot, turnip, and cucumber) sourced from both local markets and retail outlets. Additionally, we investigated the antibiotic resistance of these bacterial species. Our findings revealed the presence of the selected bacterial species, E. coli, Salmonella spp., S. aureus, in all samples obtained from both retail outlets and local markets. Notably, from among the local markets, pear exhibited the highest bacterial load (4.29 × 105 CFU/gm) compared to guava (3.16 × 105 CFU/gm) and apple (2.83 × 105 CFU/gm). Among vegetables, carrots demonstrated the highest contamination (4.27 × 105 CFU/gm) compared to turnip (3.38 × 105 CFU/gm) and cucumber (2.45 × 105 CFU/gm). Similar pattern was also obtained from among the common retail outlets. Pear exhibited itself as the most contaminated fruit (2.13 × 105 CFU/gm), followed by guavas (1.43 × 105 CFU/gm) and apples (0.882 × 105 CFU/gm). Among vegetables, carrots exhibited the maximum contamination (2.31 × 105 CFU/gm) compared to turnip (1.05 × 105 CFU/gm) and cucumber (0.689 × 105 CFU/gm). Comparing the presence of various microbes among the available fresh produce, it was observed that E. coli consistently showed the highest abundance amongst all bacterial species cultivated from the fresh produce of both local markets and retail outlets. Alarmingly, isolated bacterial species also displayed substantial resistance to commonly used broad-spectrum antibiotics, emphasizing the inherent health risks posed by bacterial pathogens present on raw fresh produce. This resistance underscores the potential threat to consumer health upon the consumption of such contaminated raw produce. We provide scientific evidence to prove that fresh produce may serve as a vehicle of foodborne exposure to antimicrobial-resistant bacteria. It’s a global alarming situation, which needs immediate attentions and steps for control. Concerted efforts should be made to mitigate the resistant bacteria at all stages of the food chain, from production to consumption. To achieve this goal, good agricultural practices should be employed and regulatory authorities need to address this problem immediately
- 29 November 2023
- Published by Green Publication
- Vol. 44 (5) , 1351-1361
Open AccessBacterial contamination and associated antibiotic resistance in Fresh Produce : A comparative study between retail outlets and local markets
The consumption of food is essential for human survival, but the presence of bacterial pathogens in fresh produce can pose significant risks to public health by causing severe foodborne and enteric diseases. With this concern in mind, our study aimed to assess the contamination levels of specific bacterial species, E. coli, Salmonella spp., and Staphylococcus aureus, in various fresh produce items (pear, guava, apple, carrot, turnip, and cucumber) sourced from both local markets and retail outlets. Additionally, we investigated the antibiotic resistance of these bacterial species. Our findings revealed the presence of the selected bacterial species, E. coli, Salmonella spp., S. aureus, in all samples obtained from both retail outlets and local markets. Notably, from among the local markets, pear exhibited the highest bacterial load (4.29 × 105 CFU/gm) compared to guava (3.16 × 105 CFU/gm) and apple (2.83 × 105 CFU/gm). Among vegetables, carrots demonstrated the highest contamination (4.27 × 105 CFU/gm) compared to turnip (3.38 × 105 CFU/gm) and cucumber (2.45 × 105 CFU/gm). Similar pattern was also obtained from among the common retail outlets. Pear exhibited itself as the most contaminated fruit (2.13 × 105 CFU/gm), followed by guavas (1.43 × 105 CFU/gm) and apples (0.882 × 105 CFU/gm). Among vegetables, carrots exhibited the maximum contamination (2.31 × 105 CFU/gm) compared to turnip (1.05 × 105 CFU/gm) and cucumber (0.689 × 105 CFU/gm). Comparing the presence of various microbes among the available fresh produce, it was observed that E. coli consistently showed the highest abundance amongst all bacterial species cultivated from the fresh produce of both local markets and retail outlets. Alarmingly, isolated bacterial species also displayed substantial resistance to commonly used broad-spectrum antibiotics, emphasizing the inherent health risks posed by bacterial pathogens present on raw fresh produce. This resistance underscores the potential threat to consumer health upon the consumption of such contaminated raw produce. We provide scientific evidence to prove that fresh produce may serve as a vehicle of foodborne exposure to antimicrobial-resistant bacteria. It’s a global alarming situation, which needs immediate attentions and steps for control. Concerted efforts should be made to mitigate the resistant bacteria at all stages of the food chain, from production to consumption. To achieve this goal, good agricultural practices should be employed and regulatory authorities need to address this problem immediately
- 25 October 2023
- Published by Springer Nature in Molecular Diversity
- Vol. 28 (5) , 3181-3198
Bactericidal activity of esculetin is associated with impaired cell wall synthesis by targeting glutamate racemase of Neisseria gonorrhoeae
Neisseria gonorrhoeae (NG), the causative organism of gonorrhea, has been classified by the World Health Organization as ‘Priority’ two organism owing to its increased resistance to antibiotics and even failure of recommended dual therapy with ceftriaxone and azithromycin. As a result, the general and reproductive health of infected individuals is severely compromised. The imminent public health catastrophe of antimicrobial-resistant gonococci cannot be understated, as t he of severe complications and sequelae of infection are not only increasing but their treatment has also become more expensive. Tenacious attempts are underway to discover novel drug targets as well as new drugs to fight against NG. Therefore, a considerable number of phytochemicals have been tested for their remedial intercession via targeting bacterial proteins. The MurI gene encodes for an enzyme called glutamate racemase (MurI) that is primarily involved in peptidoglycan (PG) biosynthesis and is specific to the bacterial kingdom and hence can be exploited as a potential drug target for the treatment of bacterial diseases. Accordingly, diverse families of phytochemicals were screened in silico for their binding affinity with N. Gonorrhoeae MurI (NG-MurI) protein. Esculetin, one of the shortlisted compounds, was evaluated for its functional, structural, and anti-bacterial activity. Treatment with esculetin resulted in growth inhibition, cell wall damage, and altered permeability as revealed by fluorescence and electron microscopy. Furthermore, esculetin inhibited the racemization activity of recombinant, purified NG-MurI protein, one of the enzymes required for peptidoglycan biosynthesis. Our results suggest that esculetin could be further explored as a lead compound for developing new drug molecules against multidrug-resistant strains.
- 25 October 2023
- Published by Springer Nature in Molecular Diversity
- Vol. 28 (5) , 3181-3198
Bactericidal activity of esculetin is associated with impaired cell wall synthesis by targeting glutamate racemase of Neisseria gonorrhoeae
Neisseria gonorrhoeae (NG), the causative organism of gonorrhea, has been classified by the World Health Organization as ‘Priority’ two organism owing to its increased resistance to antibiotics and even failure of recommended dual therapy with ceftriaxone and azithromycin. As a result, the general and reproductive health of infected individuals is severely compromised. The imminent public health catastrophe of antimicrobial-resistant gonococci cannot be understated, as t he of severe complications and sequelae of infection are not only increasing but their treatment has also become more expensive. Tenacious attempts are underway to discover novel drug targets as well as new drugs to fight against NG. Therefore, a considerable number of phytochemicals have been tested for their remedial intercession via targeting bacterial proteins. The MurI gene encodes for an enzyme called glutamate racemase (MurI) that is primarily involved in peptidoglycan (PG) biosynthesis and is specific to the bacterial kingdom and hence can be exploited as a potential drug target for the treatment of bacterial diseases. Accordingly, diverse families of phytochemicals were screened in silico for their binding affinity with N. Gonorrhoeae MurI (NG-MurI) protein. Esculetin, one of the shortlisted compounds, was evaluated for its functional, structural, and anti-bacterial activity. Treatment with esculetin resulted in growth inhibition, cell wall damage, and altered permeability as revealed by fluorescence and electron microscopy. Furthermore, esculetin inhibited the racemization activity of recombinant, purified NG-MurI protein, one of the enzymes required for peptidoglycan biosynthesis. Our results suggest that esculetin could be further explored as a lead compound for developing new drug molecules against multidrug-resistant strains.
- Open Access
In silico multi-epitope vaccine against covid19 showing effective interaction with HLA-B*15:03
The recent outbreak of severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) causing coronavirus disease (covid19) has posed a great threat to human health. Previous outbreaks of SARS-CoV and Middle East respiratory Syndrome CoV (MERS-CoV) from the same CoV family had posed similar threat to human health and economic growth. To date, not even a single drug specific to any of these CoVs has been developed nor any anti-viral vaccine is available for the treatment of diseases caused by CoVs. Subunits present in spike glycoproteins of SARS-CoV and SARS-CoV-2 are involved in binding to human ACE2 Receptor which is the primary method of viral invasion. As it has been observed in the previous studies that there are very minor differences in the spike glycoproteins of SARS-CoV and SARS-CoV-2. SARS-CoV-2 has an additional furin cleavage site that makes it different from SARS-CoV (Walls et al., 2020). In this study, we have analyzed spike glycoproteins of SARS-CoV-2 and SARS-CoV phylogenetically and subjected them to selection pressure analysis. Selection pressure analysis has revealed some important sites in SARS-CoV-2 and SARS-CoV spike glycoproteins that might be involved in their pathogenicity. Further, we have developed a potential multi-epitope vaccine candidate against SARS-CoV-2 by analyzing its interactions with HLA-B*15:03 subtype. This vaccine consists of multiple T-helper (TH) cells, B-cells, and Cytotoxic T-cells (CTL) epitopes joined by linkers and an adjuvant to increase its immunogenicity. Conservation of selected epitopes in SARS, MERS, and human hosts, suggests that the designed vaccine could provide cross-protection. The vaccine is designed in silico by following a reverse vaccinology method acknowledging its antigenicity, immunogenicity, toxicity, and allergenicity. The vaccine candidate that we have designed as a result of this work shows promising result indicating its potential capability of simulating an immune response.
Open AccessIn silico multi-epitope vaccine against covid19 showing effective interaction with HLA-B*15:03
The recent outbreak of severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) causing coronavirus disease (covid19) has posed a great threat to human health. Previous outbreaks of SARS-CoV and Middle East respiratory Syndrome CoV (MERS-CoV) from the same CoV family had posed similar threat to human health and economic growth. To date, not even a single drug specific to any of these CoVs has been developed nor any anti-viral vaccine is available for the treatment of diseases caused by CoVs. Subunits present in spike glycoproteins of SARS-CoV and SARS-CoV-2 are involved in binding to human ACE2 Receptor which is the primary method of viral invasion. As it has been observed in the previous studies that there are very minor differences in the spike glycoproteins of SARS-CoV and SARS-CoV-2. SARS-CoV-2 has an additional furin cleavage site that makes it different from SARS-CoV (Walls et al., 2020). In this study, we have analyzed spike glycoproteins of SARS-CoV-2 and SARS-CoV phylogenetically and subjected them to selection pressure analysis. Selection pressure analysis has revealed some important sites in SARS-CoV-2 and SARS-CoV spike glycoproteins that might be involved in their pathogenicity. Further, we have developed a potential multi-epitope vaccine candidate against SARS-CoV-2 by analyzing its interactions with HLA-B*15:03 subtype. This vaccine consists of multiple T-helper (TH) cells, B-cells, and Cytotoxic T-cells (CTL) epitopes joined by linkers and an adjuvant to increase its immunogenicity. Conservation of selected epitopes in SARS, MERS, and human hosts, suggests that the designed vaccine could provide cross-protection. The vaccine is designed in silico by following a reverse vaccinology method acknowledging its antigenicity, immunogenicity, toxicity, and allergenicity. The vaccine candidate that we have designed as a result of this work shows promising result indicating its potential capability of simulating an immune response.